Circulation parameters during intravenous and intra-arterial administration of increasing doses of prostaglandin E1 in healthy subjects

Klinische Wochenschrift

Volumn 63, Issue 23, 1985, Pages 1201-1204

  Brecht, Th ^a   Ayaz, M ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Circulation parameters; Intra arterial administration; Intravenous administration; Prostaglandin E1

Indexed keywords

NUCLEOSIDE; NUCLEOTIDE; PROSTAGLANDIN E1;

BLOOD FLOW; CARDIOVASCULAR SYSTEM; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NORMAL HUMAN; PRIORITY JOURNAL; THERAPY;

ADULT; ALPROSTADIL; BLOOD PRESSURE; CARDIAC OUTPUT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART RATE; HEMODYNAMICS; HUMAN; INFUSIONS, PARENTERAL; INJECTIONS, INTRA-ARTERIAL; LEG; MALE; REGIONAL BLOOD FLOW;

EID: 0022396991     PISSN: 00232173     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/BF01733778     Document Type: Article

References (24)

1. Über eine konservative Therapie arterieller Verschlußkrankheiten auf rationaler Basis
2. Die konservative Therapie der arteriellen Verschlußkrankheit
3. Epoprostenol (Prostacyclin) and severe arterial disease. A double blind trial
4. Observations on the effects of infusion of prostaglandin E in man
5. Femoral artery infusion of prostaglandin E1 in severe peripheral vascular disease
6. Prostaglandin E1 (PGE1) in peripheral arteriographies
7. Effects of i.v. and i.a. prostaglandin E1 on dog forelimb skin and muscle blood flow
8. The effects of local and systemic infusion of prostaglandin E1 on skin and muscle vasculation of the dog forelimb
9. A controlled study showing significant shortterm effect of prostaglandin E1 in healing of ischemic ulcers of the lower limbs in man
10. Prostaglandin E1 and its effect on the nutritional circulation in ischemic skin areas
11. Prostaglandins. Their disappearance from and release into the circulation
12. Conservative treatment of inoperable arterial occlusions of the lower extremities with intraarterial prostaglandin E1
13. Vitalkapillarmikroskopische Untersuchungen und transkutane PO2-Messungen bei i.v. — Prostaglandin E1 Infusion
14. Die Wirkung eines Nukleotid-Nukleosidgemisches auf die hypoxische Stoffwechselumstellung bei ergometrischer Belastung durchblutungsgestörter Gliedmaßen
15. Hemodynamic effects of intravenous PGE1 on patients with arterial occlusive disease of the leg
16. Langzeitinfusion mit Prostacyclin (PGI2) bei Patienten mit arterieller Verschlußkrankheit im Stadium III–IV
17. Prostaglandin E1 for impending gangrene
18. Prostaglandin E1 in severe Raynauds phenomenon
19. Inactivation of prostaglandins by the lung
20. Effekte von Prostaglandin E1 auf Haemodynamik und Extremitätenstoffwechsel bei Gesunden und Patienten
21. Effect of eight prostaglandins in platelet aggregation
22. Effect of intra-arterial infusion of PGE1 in patients with severe ischemia of lower extremity